Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Anheuser-Busch InBev SA/NV (BUD) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Anheuser-Busch InBev SA/NV (BUD) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for January 17th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 17th:
Rayonier Advanced Materials Inc. (RYAM - Free Report) : This cellulose specialty products company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its next year earnings increasing 25% over the last 60 days.
Rayonier Advanced Materials Inc. Price and Consensus
Rayonier Advanced Materials Inc. price-consensus-chart | Rayonier Advanced Materials Inc. Quote
Rayonier’s shares gained 93.4% over the last three months compared with the S&P 500’s advance of 6.6%. The company possesses a Momentum Scoreof A.
Rayonier Advanced Materials Inc. Price
Rayonier Advanced Materials Inc. price | Rayonier Advanced Materials Inc. Quote
Anheuser-BuschInBev SA/NV (BUD - Free Report) : This maker of alcoholic and non-alcoholic beverages has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3% over the last 60 days.
AnheuserBusch InBev SANV Price and Consensus
AnheuserBusch InBev SANV price-consensus-chart | AnheuserBusch InBev SANV Quote
Anheuser-Busch’s shares gained 29.8% over the last three months compared with the S&P 500’s advance of 6.6%. The company possesses a Momentum Score of A.
AnheuserBusch InBev SANV Price
AnheuserBusch InBev SANV price | AnheuserBusch InBev SANV Quote
Kala Pharmaceuticals, Inc. (KALA - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Kala Pharmaceuticals, Inc. Price and Consensus
Kala Pharmaceuticals, Inc. price-consensus-chart | Kala Pharmaceuticals, Inc. Quote
Kala’s shares gained 46.5% over the last three months compared with the S&P 500’s advance of 6.6%. The company possesses a Momentum Score of A.
Kala Pharmaceuticals, Inc. Price
Kala Pharmaceuticals, Inc. price | Kala Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.